BioCentury
ARTICLE | Clinical News

Aptocine talaporfin sodium: Completed Phase III enrollment

March 8, 2010 8:00 AM UTC

Light Sciences completed enrollment of 450 patients in an open-label, international Phase III trial comparing Aptocine plus chemotherapy vs. chemotherapy alone. The company also said the occurrence of...